<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04238572</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A01243-54</org_study_id>
    <nct_id>NCT04238572</nct_id>
  </id_info>
  <brief_title>Evaluation of Immersive Audiovisual Distraction Impact on Peroperative Opioid Consumption.</brief_title>
  <acronym>AmbuCineView</acronym>
  <official_title>Evaluation of an Immersive Audiovisual Distraction Device Impact on Peroperative Opioid Consumption. A Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the impact of an audiovisual distraction device on the peroperative
      opioid consumption for outpatient procedures with Remifentanil added to local anesthesia.

      Half of patients will receive an audiovisual distraction device while the other half not.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early recovery for patients undergoing surgery is the key factor for an outpatient procedure.

      The technique of adding remifentanil to a local anesthesia is used in 22% of the procedures
      realized in The CHU de Caen Outpatient unit. Decreasing opioid dose, whose side effects are
      numerous and widely described, as well as reducing anxiety are daily challenges to ensure
      comfort and successful care.

      We propose a prospective, randomized, monocentric, open label study to evaluate the impact of
      the use of an audiovisual distraction device on the intraoperative consumption of opioids, on
      the patient's pain and peroperative anxiety.

      ANI (Analgesia Nociception Index) will be used for peroperative overall comfort measurement.
      We will analyze if audiovisual distraction can integrate existing techniques such as
      hypnosis.

      Finally, we will also assess the medico-economic impact of this technique in order to
      establish a benefit / cost ratio.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2020</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>200 patients will be randomized. 100 patients operated on in vitro fertilization (50 patients in intervention group, 50 patients in active comparator group) 100 patients operated on venous access port placement (50 patients in intervention group, 50 patients in active comparator group)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative Remifentanil dose</measure>
    <time_frame>1 hour</time_frame>
    <description>μg/kg/min</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preoperative pain measured with a numeric pain rating scale (NRS)</measure>
    <time_frame>1 hour</time_frame>
    <description>Numeric pain rating scale (0 = No pain to 10 = Worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative anxiety measured by the Amsterdam Preoperative Anxiety and Information Scale (APAIS)</measure>
    <time_frame>1 hour</time_frame>
    <description>APAIS measures the need-for-information with 6 items. Each one is rated from 1 = Not at all to 5 = Extremely. There is positive and significant correlation between the ned-for-information and anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative anxiety measured by a visual analogue scale (VAS)</measure>
    <time_frame>1 hour</time_frame>
    <description>Visual analogue scale is a 100mm horizontal line. At the left hand (0mm) the statement &quot;not anxious at all&quot; and at the right hand (100mm) the statement &quot;most anxious I can imagine&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per operative Analgesia nociception index (ANI) value</measure>
    <time_frame>1 hour</time_frame>
    <description>From 0 = Predominant sympathetic tone, pain and anxiety to 100 = Predominant parasympathetic tone, good analgesia.
Negative linear Relationship between analgesia nociception index and pain scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative anxiety measured by a visual analogue scale (VAS)</measure>
    <time_frame>1 hour</time_frame>
    <description>Visual analogue scale is a 100mm horizontal line. At the left hand (0mm) the statement &quot;not anxious at all&quot; and at the right hand (100mm) the statement &quot;most anxious I can imagine&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain measured with a numeric pain rating scale (NRS)</measure>
    <time_frame>1 hour</time_frame>
    <description>Numeric pain rating scale (0 = No pain to 10 = Worst pain imaginable)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Surgical Procedure, Unspecified</condition>
  <condition>Analgesia</condition>
  <condition>Outpatient</condition>
  <arm_group>
    <arm_group_label>Audiovisual distraction device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Audiovisual distraction device, analgesia nociception index monitoring, remifentanil added to local anesthesia technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active comparator group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Analgesia nociception index monitoring, remifentanil added to local anesthesia technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Audiovisual distraction device</intervention_name>
    <description>Evaluate the impact of an audiovisual distraction device on the peroperative opioid consumption</description>
    <arm_group_label>Audiovisual distraction device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Analgesia nociception index</intervention_name>
    <description>ANI (Analgesia Nociception Index) will be used for peroperative overall comfort measurement</description>
    <arm_group_label>Active comparator group</arm_group_label>
    <arm_group_label>Audiovisual distraction device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient

          -  Signed consent

          -  Outpatient surgery eligibility

          -  Patient covered by social security

        Exclusion Criteria:

          -  Unsigned consent

          -  Study participation refusal

          -  Deafness, blindness

          -  Claustrophobia

          -  ANI contraindication (atrial fibrillation, pace maker, severe autonomic system
             dysfunction)

          -  Contraindication or impossibility to use the audiovisual distraction device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clément Buléon, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Caen UH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clément Buléon, MD</last_name>
    <phone>0231063000</phone>
    <email>buleon-c@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marin Delaby, Resident</last_name>
    <phone>0679866671</phone>
    <email>marin.delaby@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Marsdin E, Noble JG, Reynard JM, Turney BW. Audiovisual distraction reduces pain perception during shockwave lithotripsy. J Endourol. 2012 May;26(5):531-4. doi: 10.1089/end.2011.0430. Epub 2012 Feb 8.</citation>
    <PMID>22098167</PMID>
  </reference>
  <reference>
    <citation>Lee DW, Chan AC, Wong SK, Fung TM, Li AC, Chan SK, Mui LM, Ng EK, Chung SC. Can visual distraction decrease the dose of patient-controlled sedation required during colonoscopy? A prospective randomized controlled trial. Endoscopy. 2004 Mar;36(3):197-201.</citation>
    <PMID>14986215</PMID>
  </reference>
  <reference>
    <citation>Eccleston C, Crombez G. Pain demands attention: a cognitive-affective model of the interruptive function of pain. Psychol Bull. 1999 May;125(3):356-66. Review.</citation>
    <PMID>10349356</PMID>
  </reference>
  <reference>
    <citation>Boselli E. Interest of Analgesia/Nociception Index (ANI) for monitoring the relative parasympathetic tone in anesthetized and awake patients. Douleurs (Paris) (2018)</citation>
  </reference>
  <reference>
    <citation>Boselli et al. Analgesia monitoring using Analgesia/Nociception Index: Results of clinical studies in awake and anesthetized patients. Le Praticien en anesthésie réanimation. 2015;19:78-86</citation>
  </reference>
  <reference>
    <citation>Logier R, Jeanne M, De Jonckheere J, Dassonneville A, Delecroix M, Tavernier B. PhysioDoloris: a monitoring device for analgesia / nociception balance evaluation using heart rate variability analysis. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:1194-7. doi: 10.1109/IEMBS.2010.5625971.</citation>
    <PMID>21095676</PMID>
  </reference>
  <reference>
    <citation>Papaioannou V, Chouvarda I, Gaertner E, Benyamina M, Ferry A, Maurel V, Soussi S, Blet A, Chaouat M, Plaud B, Mebazaa A, Legrand M; PRONOBURN Group. Heart rate variability and cardiac baroreflex inhibition-derived index predicts pain perception in burn patients. Burns. 2016 Nov;42(7):1445-1454. doi: 10.1016/j.burns.2016.04.017. Epub 2016 May 8.</citation>
    <PMID>27170468</PMID>
  </reference>
  <reference>
    <citation>Issa R, Julien M, Décary E, Verdonck O, Fortier LP, Drolet P, Richebé P. Evaluation of the analgesia nociception index (ANI) in healthy awake volunteers. Can J Anaesth. 2017 Aug;64(8):828-835. doi: 10.1007/s12630-017-0887-z. Epub 2017 Apr 21.</citation>
    <PMID>28432612</PMID>
  </reference>
  <reference>
    <citation>Boselli E, Musellec H, Martin L, Bernard F, Fusco N, Guillou N, Hugot P, Paqueron X, Yven T, Virot C. Effects of hypnosis on the relative parasympathetic tone assessed by ANI (Analgesia/Nociception Index) in healthy volunteers: a prospective observational study. J Clin Monit Comput. 2018 Jun;32(3):487-492. doi: 10.1007/s10877-017-0056-5. Epub 2017 Aug 20.</citation>
    <PMID>28825157</PMID>
  </reference>
  <reference>
    <citation>Le Guen M, Jeanne M, Sievert K, Al Moubarik M, Chazot T, Laloë PA, Dreyfus JF, Fischler M. The Analgesia Nociception Index: a pilot study to evaluation of a new pain parameter during labor. Int J Obstet Anesth. 2012 Apr;21(2):146-51. doi: 10.1016/j.ijoa.2012.01.001. Epub 2012 Feb 21.</citation>
    <PMID>22360936</PMID>
  </reference>
  <reference>
    <citation>Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth. 2014 Jun;112(6):991-1004. doi: 10.1093/bja/aeu137. Review.</citation>
    <PMID>24829420</PMID>
  </reference>
  <reference>
    <citation>Yi P, Pryzbylkowski P. Opioid Induced Hyperalgesia. Pain Med. 2015 Oct;16 Suppl 1:S32-6. doi: 10.1111/pme.12914. Review.</citation>
    <PMID>26461074</PMID>
  </reference>
  <reference>
    <citation>Maurice-Szamburski A, Loundou A, Capdevila X, Bruder N, Auquier P. Validation of the French version of the Amsterdam preoperative anxiety and information scale (APAIS). Health Qual Life Outcomes. 2013 Oct 7;11:166. doi: 10.1186/1477-7525-11-166.</citation>
    <PMID>24099176</PMID>
  </reference>
  <reference>
    <citation>Facco E, Stellini E, Bacci C, Manani G, Pavan C, Cavallin F, Zanette G. Validation of visual analogue scale for anxiety (VAS-A) in preanesthesia evaluation. Minerva Anestesiol. 2013 Dec;79(12):1389-95. Epub 2013 Jul 9.</citation>
    <PMID>23860442</PMID>
  </reference>
  <reference>
    <citation>Abend R, Dan O, Maoz K, Raz S, Bar-Haim Y. Reliability, validity and sensitivity of a computerized visual analog scale measuring state anxiety. J Behav Ther Exp Psychiatry. 2014 Dec;45(4):447-53. doi: 10.1016/j.jbtep.2014.06.004. Epub 2014 Jun 18.</citation>
    <PMID>24978117</PMID>
  </reference>
  <reference>
    <citation>Hornblow AR, Kidson MA. The visual analogue scale for anxiety: a validation study. Aust N Z J Psychiatry. 1976 Dec;10(4):339-41.</citation>
    <PMID>1071419</PMID>
  </reference>
  <reference>
    <citation>Kindler CH, Harms C, Amsler F, Ihde-Scholl T, Scheidegger D. The visual analog scale allows effective measurement of preoperative anxiety and detection of patients' anesthetic concerns. Anesth Analg. 2000 Mar;90(3):706-12.</citation>
    <PMID>10702461</PMID>
  </reference>
  <results_reference>
    <citation>Wismeijer AA, Vingerhoets AJ. The use of virtual reality and audiovisual eyeglass systems as adjunct analgesic techniques: a review of the literature. Ann Behav Med. 2005 Dec;30(3):268-78. Review.</citation>
    <PMID>16336078</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 17, 2020</study_first_submitted>
  <study_first_submitted_qc>January 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2020</study_first_posted>
  <last_update_submitted>January 22, 2020</last_update_submitted>
  <last_update_submitted_qc>January 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Audiovisual distraction device</keyword>
  <keyword>Peroperative opioid analgesia</keyword>
  <keyword>Ambulatory care</keyword>
  <keyword>Outpatient</keyword>
  <keyword>Analgesia nociception index</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Remifentanil</keyword>
  <keyword>Remifentanil added to local anesthesia</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

